Virpax Pharmaceuticals, Inc. (VRPX) delivered a return of -99.79% over the past year. Since VRPX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Virpax Pharmaceuticals, Inc. one year ago would be worth $21 today, representing a loss of $9,979.

Virpax Pharmaceuticals, Inc. (VRPX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VRPX, the total return equals the price-only return.

No, Virpax Pharmaceuticals, Inc. (VRPX) underperformed the S&P 500 by 122.65 percentage points over the past year. VRPX delivered a total return of -99.79%, compared to the S&P 500's 22.86%. This means a passive S&P 500 index fund outperformed VRPX by 122.65pp during this period.

Virpax Pharmaceuticals, Inc. (VRPX) experienced a maximum drawdown of -99.98% over the past year, declining from its peak on 2025-06-24 to its trough on 2026-03-25. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Virpax Pharmaceuticals, Inc. (VRPX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% — $10,000 would have grown to $0. Over 20 years: -100.0% total return — $10,000 → $0. Over 30 years: -100.0% total return — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Virpax Pharmaceuticals, Inc.'s best calendar year was 2021 with a total return of -47.5%. Its worst year was 2025 with a total return of -99.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 52.4 percentage points.